About Immunoprotein Diagnostic Testing Immunoproteins are blood proteins that act as the body's defense mechanism. They also play a major role in the functioning of the immune system. Immunoprotein diagnostic testing helps detect several diseases such as cancers, allergies, influenza, and other autoimmune diseases. The concentration of immunoproteins within the body is used as an indicator to diagnose diseases. Based on application, the global immunoprotein diagnostic testing market has been segmented into infectious disease testing, allergy testing, oncology and endocrinology testing, and autoimmune testing. Technavio’s analysts forecast the global immunoprotein diagnostic testing market to grow at a CAGR of 7.89% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global immunoprotein diagnostic testing market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Immunoprotein Diagnostic Testing Market 2017-2021, has been prepared based... Research Beam Model: Research Beam Product ID: 2141536 3500 USD New
Global Immunoprotein Diagnostic Testing Market 2017-2021
 
 

Global Immunoprotein Diagnostic Testing Market 2017-2021

  • Category : Healthcare
  • Published On : September   2017
  • Pages : 96
  • Publisher : Technavio
 
 
 
About Immunoprotein Diagnostic Testing

Immunoproteins are blood proteins that act as the body's defense mechanism. They also play a major role in the functioning of the immune system. Immunoprotein diagnostic testing helps detect several diseases such as cancers, allergies, influenza, and other autoimmune diseases. The concentration of immunoproteins within the body is used as an indicator to diagnose diseases. Based on application, the global immunoprotein diagnostic testing market has been segmented into infectious disease testing, allergy testing, oncology and endocrinology testing, and autoimmune testing.

Technavio’s analysts forecast the global immunoprotein diagnostic testing market to grow at a CAGR of 7.89% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global immunoprotein diagnostic testing market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Immunoprotein Diagnostic Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Beckman Coulter
• DiaSorin
• F. Hoffmann-La Roche
• Siemens Healthineers

Other prominent vendors
• Menarini Diagnostics
• Abcam
• Adaltis
• Affymetrix
• Agilent Technologies
• Biomedical diagnostics
• bioMérieux
• Bio-Rad Laboratories
• Bioo Scientific
• Certest Biotec
• Corgenix
• CorisBioconcept
• Coyote Bioscience
• DML
• EIKEN CHEMICAL
• EKF Diagnostics
• Enzo Life Sciences
• EUROIMMUN
• Fitzgerald Industries
• Fujirebio Diagnostics
• Gentian
• Grifols
• IBL International
• Immunodiagnostic Systems
• ImmunoDX
• Instrumentation Laboratory
• Kyowa Medex
• Merck Millipore
• Meridian Bioscience
• NecLife
• Operon - Inmuno & Molecular Diagnostics
• ORGENTEC Diagnostika
• Ortho-Clinical Diagnostics
• PerkinElmer
• QIAGEN
• Quest Diagnostics
• Quidel
• Sekisui Diagnostics
• SQI Diagnostics
• Standard Diagnostics
• Sysmex
• Technopath Clinical Diagnostics
• The Binding Site Group
• Thermo Fisher Scientific
• Tosoh Bioscience
• Trinity Biotech
• Tulip Diagnostics
• Wako

Market driver
• Increasing use of immunochromatography-based cassette kits or test strips
• For a full, detailed list, view our report

Market challenge
• Limited capability and high complexity of procedure
• For a full, detailed list, view our report

Market trend
• Growing focus on next-generation products
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Overview
• Market size and forecast
• Five forces analysis
PART 06: Segmentation by application
• Overview
• Infectious disease testing
• Oncology and endocrinology testing
• Autoimmune testing
• Allergy testing
PART 07: Segmentation by end-user
• Overview
• Hospital and clinics
• Diagnostic laboratories
PART 08: Segmentation by geography
• Overview
• Americas
• EMEA
• APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• Growing focus on next-generation products
• Increasing use of cloud-based solutions
• Emergence of nanoparticle-based immunoassay for protein test
PART 12: Vendor landscape
• Competitive landscape
PART 13: Key vendor analysis
• Beckman Coulter
• DiaSorin
• F. Hoffmann-La Roche
• Siemens Healthineers
• Key companies to watch
• Other prominent vendors
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Share of global immunoprotein diagnostic testing market in global immunoassay market 2016
Exhibit 02: Global immunoprotein diagnostic testing market: Overview 2016-2021
Exhibit 03: Global immunoprotein diagnostic testing market 2016-2021 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global immunoprotein diagnostic testing market: Overview of segmentation by application
Exhibit 06: Global infectious disease testing market 2016-2021 ($ billions)
Exhibit 07: Global oncology and endocrinology testing market 2016-2021 ($ billions)
Exhibit 08: Global autoimmune testing market 2016-2021 ($ billions)
Exhibit 09: Global allergy testing market 2016-2021 ($ billions)
Exhibit 10: Global immunoprotein diagnostic testing market: Overview of segmentation by end-users
Exhibit 11: Global immunoprotein diagnostic testing market: Buying criteria of end-users
Exhibit 12: Global immunoprotein diagnostic testing market: Overview of segmentation by geography
Exhibit 13: Immunoprotein diagnostic testing market in Americas: Overview
Exhibit 14: Immunoprotein diagnostic testing market in Americas 2016-2021 ($ billions)
Exhibit 15: Immunoprotein diagnostic testing market in EMEA: Overview
Exhibit 16: Immunoprotein diagnostic testing market in EMEA 2016-2021 ($ billions
Exhibit 17: Immunoprotein diagnostic testing market in APAC: Overview
Exhibit 18: Immunoprotein diagnostic testing market in APAC 2016-2021 ($ billions)
Exhibit 19: Prevalence of infectious diseases
Exhibit 20: Companies offering chromatographic tests
Exhibit 21: Automation products offered by vendors
Exhibit 22: Cost of immunoprotein diagnostic testing products developed by Beckman Coulter
Exhibit 23: Global immunoprotein diagnostic testing market: Competitive structure analysis 2016
Exhibit 24: Global immunoprotein diagnostic testing market: Participants 2016
Exhibit 25: Global immunoprotein diagnostic testing market: Strategic success factors of companies 2016
Exhibit 26: Beckman Coulter: Key highlights
Exhibit 27: Beckman Coulter: Strength assessment
Exhibit 28: Beckman Coulter: Strategy assessment
Exhibit 29: Beckman Coulter: Opportunity assessment
Exhibit 30: DiaSorin: Key highlights
Exhibit 31: DiaSorin: Strength assessment
Exhibit 32: DiaSorin: Strategy assessment
Exhibit 33: DiaSorin: Opportunity assessment
Exhibit 34: F. Hoffmann-La Roche: Key highlights
Exhibit 35: F. Hoffmann-La Roche: Strength assessment
Exhibit 36: F. Hoffmann-La Roche: Strategy assessment
Exhibit 37: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 38: Siemens Healthineers: Key highlights
Exhibit 39: Siemens Healthineers: Strength assessment
Exhibit 40: Siemens Healthineers: Strategy assessment
Exhibit 41: Siemens Healthineers: Opportunity assessment
Exhibit 42: Abbott: Overview
Exhibit 43: Alere: Overview

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT